Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal | 7-KETO® | US | 7199116 |
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Synorome by the Administration of Delta5-Androstene-3beta-Ol-7,17 Dione and Metabolizable Precursors Thereof | 7-KETO® | US | 7553829 |
Immunoglobulin Variants | AggreSolveâ„¢ Screening Technology | JP | 5901522 |
Immunoglobulin Variants | AggreSolveâ„¢ Screening Technology | US | 9290563 |
Immunoglobulin Variants | AggreSolveâ„¢ Screening Technology | US | 8951516 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | JP | 6169520 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | JP | 5559439 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | NL | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | US | 10214560 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | US | 10294270 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | CH | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | CN | ZL201280010479.6 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | CN | ZL 201510163661.0 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | DE | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | ES | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | FR | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | GB | 2678037 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | HK | 1213773 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | HK | 1186668 |
Branched Linkers For Protein Drug Conjugates | Antibody Drug Conjugates | IT | 2678037 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | US | 10357455 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | US | 9486410 |
Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | DE | 602004031767.5 |
Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | FR | 1701703 |
Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs, Poloxamers And Stabilizing Polymers | ASD Compositions | GB | 1701703 |
Pharmaceutical Compositions With Enhanced Performance | ASD Compositions | US | 8207232 |
Pharmaceutical Compositions With Enhanced Performance | ASD Compositions | US | 8940800 |
Pharmaceutical Compositions Of Drugs And Neutralized Acidic Polymers | ASD Compositions | US | 8147872 |
Pharmaceutical Compositions Of Drugs And Neutralized Acidic Polymers | ASD Compositions | US | 8173142 |
Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers | ASD Compositions | US | 9468604 |
Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | DE | 602007008470.9 |
Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | FR | 2101741 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | DE | 60320940.8 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | DE | 1920766 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | FR | 1469832 |
Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | GB | 2101741 |
Solid Dispersion Comprising A Poorly Water Soluble Drug | ASD Compositions | IE | 2101741 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | FR | 1920766 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | GB | 1920766 |
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials | ASD Compositions | GB | 1469832 |
Spray Dried Formulation | ASD Compositions | US | 8372836 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | BE | 2956121 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | DE | 602014026156.6 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | FR | 2956121 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | GB | 2956121 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | JP | 6396333 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | US | 9737538 |
Solid Dispersions Of Low-Water Solubility Actives | ASD Compositions | US | 10322126 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | BE | 1942878 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | DE | 602006041222.3 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | ES | 1942878 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | FR | 1942878 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | GB | 1942878 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | IT | 1942878 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | JP | 5522937 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base | Capsule - Banding | NL | 1942878 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | US | 11246837 |
Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (HPMC) As A Base | Capsule - Banding | US | 9579290 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | JP | 6836977 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | NL | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | US | 9980918 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | BE | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | CZ | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | DE | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | ES | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | FR | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | GB | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | IT | 2776016 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | JP | 6219836 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | BE | 3167880 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | DE | 3167880 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | FR | 3167880 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | GB | 3167880 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | JP | 6768060 |
Liquid Filled Delivery System | Capsule - Fill Formulations | US | 8795720 |
Delivery Carrier | Capsule - Fill Formulations | DE | 602010025605.7 |
Delivery Carrier | Capsule - Fill Formulations | FR | 2498760 |
Delivery Carrier | Capsule - Fill Formulations | GB | 2498760 |
Delivery Carrier | Capsule - Fill Formulations | US | 9333177 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | US | 10166187 |
Capsule Formulation Comprising Bifidobacterium Bacteria and the Production Method Thereof | Capsule - Fill Formulations | JP | 6297441 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | BE | 2358328 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | FR | 2358328 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | GB | 2358328 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | JP | 5642081 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | MX | 316978 |
Liquid Pump | Capsule Manufacturing Process & Equipment | BE | 2185817 |
Liquid Pump | Capsule Manufacturing Process & Equipment | DE | 602008050408.5 |
Liquid Pump | Capsule Manufacturing Process & Equipment | FR | 2185817 |
Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | DE | 602004027364.3 |
Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | FR | 1459725 |
Apparatus for and Method of Sealing Capsules | Capsule Manufacturing Process & Equipment | GB | 1617800 |
Transfer Line | Capsule Manufacturing Process & Equipment | BE | 2457551 |
Transfer Line | Capsule Manufacturing Process & Equipment | DE | 602007040166.6 |
Transfer Line | Capsule Manufacturing Process & Equipment | DE | 602007027363.3 |
Transfer Line | Capsule Manufacturing Process & Equipment | ES | 2457551 |
Transfer Line | Capsule Manufacturing Process & Equipment | FR | 2457551 |
Liquid Pump | Capsule Manufacturing Process & Equipment | GB | 2185817 |
Liquid Pump | Capsule Manufacturing Process & Equipment | IT | 2185817 |
Sealing Clamp for Capsule Sealing + | Capsule Manufacturing Process & Equipment | MX | 265293 |
Apparatus for Sealing a Pharmaceutically Acceptable Hard Shell Capsule | Capsule Manufacturing Process & Equipment | US | 8491298 |
Transfer Line | Capsule Manufacturing Process & Equipment | FR | 2083787 |
Transfer Line | Capsule Manufacturing Process & Equipment | GB | 2457551 |
Transfer Line | Capsule Manufacturing Process & Equipment | IT | 2457551 |
Transfer Line | Capsule Manufacturing Process & Equipment | MX | 301695 |
Liquid Pump | Capsule Manufacturing Process & Equipment | JP | 5452488 |
Liquid Pump | Capsule Manufacturing Process & Equipment | MX | 324362 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | BE | 2049064 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | BR | PI0715125-0 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | CA | 2660037 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | CN | 200780029122.1 |
Transfer Line | Capsule Manufacturing Process & Equipment | US | 8671650 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | DE | 602007009693.6 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | ES | 2049064 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | FR | 2049064 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | GB | 2049064 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | IT | 2049064 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | JP | 5197596 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | MX | 291834 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | US | 8181425 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | BE | 2049313 |
Method of Sealing a Hard Shell Capsule | Capsule Manufacturing Process & Equipment | US | 7645407 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | CA | 2660041 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | DE | 602007043597.8 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | FR | 2049313 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | GB | 2049313 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | US | 8646591 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | JP | 5128596 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | MX | 298203 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | US | 8398912 |
Gelatin Capsules And Gelatin Compositions For Forming Capsule Coating | Capsule Manufacturing Process & Equipment | JP | 5766205 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | BE | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | DE | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | ES | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | FR | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | GB | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | IT | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | NL | 3709007 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | BE | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | DE | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | ES | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | FR | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | GB | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | IT | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | NL | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | JP | 6000260 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | NL | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | NL | 3021108 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | US | 9414027 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | US | 9575011 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | US | 10113977 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | BE | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | BE | 2625509 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | CN | ZL201180059062.4 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | DE | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | DE | 602011021060.2 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | ES | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | ES | 2625509 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | FR | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | FR | 3021108 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | GB | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | GB | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | IT | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | IT | 2625509 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | AT | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | BE | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | CA | 2775227 |
Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsule Material (alternate poly.) | BR | P10717123-4 |
Hydroxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsule Material (alternate poly.) | CA | 2667167 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | CN | 201080042764.7 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | CZ | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | DE | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | DK | 2480218 |
Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsule Material (alternate poly.) | ID | IDP000039591 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | ES | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | FR | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | GB | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | IN | 342484 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | IT | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | JP | 5777625 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | KR | 10-1762460 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | MX | 334274 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | NL | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | PL | 2480218 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | US | 10874619 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | US | 10231934 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | US | 9700517 |
Acid Resistant Capsules | Capsule Material (alternate poly.) | US | 8852631 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | Capsule Material (alternate poly.) | JP | 6887456 |
Capsules With Opacifier | Capsule Material (alternate poly.) | FR | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | GB | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | BE | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | ES | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | IT | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | NL | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | CH | 3758685 |
Capsules With Opacifier | Capsule Material (alternate poly.) | DE | 3758685 |
Multi-Compartmented Container | Capsules | US | 8968717 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | BE | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | DE | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | ES | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | FR | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | GB | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | IT | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | NL | 2852412 |
Multi-Compartmented Container | Capsules | BE | 2211820 |
Multi-Compartmented Container | Capsules | DE | 602008015434.3 |
Multi-Compartmented Container | Capsules | FR | 2211820 |
Multi-Compartmented Container | Capsules | GB | 2211820 |
Multi-Compartmented Container | Capsules | JP | 5667874 |
Multi-Compartmented Container | Capsules | US | 9456990 |
Sprinkle Design | Capsules | EM | 002542522-0006 |
Sprinkle Design | Capsules | EM | 002542522-0002 |
Sprinkle Design | Capsules | EM | 002542522-0005 |
Sprinkle Design | Capsules | EM | 002542522-0004 |
Separable Capsule | Capsules | CA | 2900305 |
Separable Capsule | Capsules | JP | 6436977 |
Separable Capsule | Capsules | US | 9775813 |
Separable Capsule | Capsules | US | 10568838 |
Hard Capsule Formulation | Capsules | JP | 6856601 |
Hard Capsule Formulation | Capsules | JP | 6420261 |
Hard Capsule Formulation | Capsules | US | 10172803 |
Sprinkle Design | Capsules | EM | 002542522-0001 |
Colloidal Dispersion Comprising HPMCAS | Capsules | US | 10471152 |
Sprinkle Design | Capsules | EM | 002542522-0003 |
Sprinkle Design | Capsules | EM | 002542522-0007 |
Multi-Compartment Dosage Form Articles | Capsules | BE | 2777802 |
Multi-Compartment Dosage Form Articles | Capsules | BE | 3077086 |
Multi-Compartment Dosage Form Articles | Capsules | CA | 2932562 |
Multi-Compartment Dosage Form Articles | Capsules | DE | 602013005497.5 |
Multi-Compartment Dosage Form Articles | Capsules | DE | 602014018609.2 |
Multi-Compartment Dosage Form Articles | Capsules | FR | 2777802 |
Multi-Compartment Dosage Form Articles | Capsules | FR | 3077086 |
Multi-Compartment Dosage Form Articles | Capsules | GB | 2777802 |
Multi-Compartment Dosage Form Articles | Capsules | GB | 3077086 |
Multi-Compartment Dosage Form Articles | Capsules | JP | 6082850 |
Multi-Compartment Dosage Form Articles | Capsules | NL | 2777802 |
Multi-Compartment Dosage Form Articles | Capsules | NL | 3077086 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | CA | 2873837 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | JP | 6306573 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsules | JP | 6598841 |
Multi-Compartment Dosage Form Articles | Capsules | US | 9561189 |
Tamperproof Oral Dosage Form | Capsules | US | 10470975 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | US | 10,603,286 |
Dosage Form Articles for Delayed Release | Capsules | FR | 3028694 |
Dosage Form Articles for Delayed Release | Capsules | GB | 3028694 |
Dosage Form Articles for Delayed Release | Capsules | BE | 3028694 |
Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | EM | 003108505-0002 |
Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | EM | 003108505-0001 |
Print or Label for a Capsule Surface (Vertical) | Capsules | EM | 003107515-0002 |
Print or Label for a Capsule Surface (Vertical) | Capsules | EM | 003107515-0001 |
Separable Capsule For Sprinkling Applications | Capsules | US | 10610490 |
Dosage Form Articles for Delayed Release | Capsules | DE | 602014011687 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | BE | 3219300 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | DE | 3219300 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | ES | 3219300 |
Dosage Form Articles | Capsules | BE | 3076954 |
Dosage Form Articles | Capsules | DE | 3076954 |
Tamperproof Oral Dosage Form | Capsules | JP | 6905512 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | FR | 3219300 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | GB | 3219300 |
Dosage Form Articles | Capsules | FR | 3076954 |
Dosage Form Articles | Capsules | GB | 3076954 |
Dosage Form Articles | Capsules | US | 9980905 |
Tamperproof Oral Dosage Form | Capsules | US | 10709640 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | IT | 3219300 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | BE | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | CH | 3199148 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | JP | 6895984 |
Dosage Form Articles for Delayed Release | Capsules | US | 10555908 |
Tamperproof Oral Dosage Form | Capsules | JP | 6905513 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | DE | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | ES | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | FR | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | GB | 3199148 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | NL | 3219300 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsules | US | 10751255 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | IT | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules | NL | 3199148 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | BE | 2632584 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | BE | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | CN | ZL201180061971.1 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | CA | 2870033 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | DE | 2844297 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | ES | 2844297 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | BE | 2844297 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | DE | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | DE | 602011040483 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | FR | 2632584 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | FR | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | GB | 2632584 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | FR | 2844297 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | GB | 2844297 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | IT | 2844297 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | JP | 6626712 |
Aqueous Dispersions Of Controlled Release Polymers And Shells And Capsules Thereof | Capsules - Enteric Capsule Technologies | US | 10525010 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | IE | 2632584 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | GB | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | IE | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | US | 10898440 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | US | 10463625 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | IT | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | IT | 2632584 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | JP | 5890428 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | KR | 10-1900966 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | NL | 2632584 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | NL | 2722104 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | US | 9198868 |
Bulk Enteric Capsule Shells | Capsules - Enteric Capsule Technologies | US | 9925148 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | BE | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | DE | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | ES | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | FR | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | GB | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | IT | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | NL | 3151815 |
Stable Dosage Form Articles for Oral Administration | Capsules - Gelita RXLâ„¢ capsules | US | 10016369 |
Container | Capsules - Licaps® capsules | CA | 2617967 |
Container | Capsules - Licaps® capsules | CN | ZL201210011817.X |
Container | Capsules - Licaps® capsules | DE | 602006038698.2 |
Container | Capsules - Licaps® capsules | ES | 1915121 |
Container | Capsules - Licaps® capsules | FR | 1915121 |
Container | Capsules - Licaps® capsules | GB | 1915121 |
Container | Capsules - Licaps® capsules | IN | 272531 |
Container | Capsules - Licaps® capsules | IT | 1915121 |
Container | Capsules - Licaps® capsules | JP | 4422779 |
Container | Capsules - Licaps® capsules | JP | 5006913 |
Container | Capsules - Licaps® capsules | MX | 309351 |
Container | Capsules - Licaps® capsules | NL | 1915121 |
Container | Capsules - Licaps® capsules | US | 8377471 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | BE | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | CA | 2722271 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | CN | 200980117292.4 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | DE | 602009008078.4 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | ES | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | FR | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | GB | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | IT | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | JP | 5716212 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | KR | 1012359510000 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | MX | 315642 |
Container | Capsules - Licaps® capsules | BE | 1915121 |
Container | Capsules - Licaps® capsules | BR | PI 0614735-6 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | US | 8715722 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | BE | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | DE | 602012011096.1 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | ES | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | FR | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | GB | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | IE | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | IT | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | JP | 5860480 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | NL | 2663294 |
New Hard Capsules Comprising Pullulan | Capsules - Plantcaps® capsules | PT | 2663294 |
Hard Capsules | Capsules - Plantcaps® capsules | US | 10568839 |
Hard Capsules | Capsules - Plantcaps® capsules | US | 10130587 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | JP | 6706254 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | US | 10525011 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | FR | 3025709 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | GB | 3025709 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | BE | 3025709 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | CA | 2965425 |
Dosage Form Articles for External Mucosal Applications | Capsules - Plantcaps® capsules | DE | 3025709 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | BE | 1539114 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | CA | 2494045 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | DE | 60335991.4 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | ES | 1539114 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | FR | 1539114 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | GB | 1539114 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | JP | 4652052 |
Colored Rigid Capsule | Capsules - Press-Fit® | JP | 4141732 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | US | 7914820 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® | US | 8557294 |
Capsule Formation | Capsules - Vcaps® capsules | DE | 602007011963.4 |
Capsule Formation | Capsules - Vcaps® capsules | ES | 2357452 |
Capsule Formation | Capsules - Vcaps® capsules | FR | 2083786 |
Capsule Formation | Capsules - Vcaps® capsules | GB | 2083786 |
Capsule Formation | Capsules - Vcaps® capsules | IT | 2083786 |
Capsule Formation | Capsules - Vcaps® capsules | JP | 5452227 |
Capsule Formation | Capsules - Vcaps® capsules | KR | 1183713 |
Capsule Formation | Capsules - Vcaps® capsules | MX | 298202 |
Capsule Formation | Capsules - Vcaps® capsules | US | 9211659 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | BE | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | CN | 200780040028.6 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | DE | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | ES | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | FR | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | GB | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | IN | 288423 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | IT | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | JP | 5372761 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | KR | 1011702830000 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | MX | 315891 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | NL | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | US | 10004692 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | US | 9655860 |
Capsule Formation | Capsules - Vcaps® capsules | BE | 2083786 |
Capsule Formation | Capsules - Vcaps® capsules | CA | 2667531 |
Capsule Formation | Capsules - Vcaps® capsules | CN | 200780040046.4 |
Capsule Formation | Capsules - Vcaps® capsules | US | 9138920 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | CH | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | BE | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | DE | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | ES | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | FR | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | GB | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | IT | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | NL | 3594248 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | DE | 602005010081.4 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | ES | 1765673 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | FR | 1765673 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | GB | 1765673 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | IT | 1765673 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | BE | 1440005 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | FR | 1440005 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | GB | 1440005 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | US | 7712634 |
Weighing Apparatus | Capsules - Xcelodose® System | DE | 602005040670 |
Weighing Apparatus | Capsules - Xcelodose® System | FR | 1792148 |
Weighing Apparatus | Capsules - Xcelodose® System | GB | 1792148 |
Weighing Apparatus | Capsules - Xcelodose® System | JP | 5420684 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | US | 8074835 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | DE | 60333075.4 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | FR | 1472138 |
Weighing Apparatus With Improved Cleaning Capabilities | Capsules - Xcelodose® System | US | 7834279 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | GB | 1472138 |
Apparatus And Method Of Dispensing Small Quantities Of Particles | Capsule Weighing Systems | US | 7665633 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | CH | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | CN | 102651974 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | CZ | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | DE | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | ES | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | FR | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | GB | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | IN | 295113 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | IT | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | JP | 6239579 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | JP | 5911806 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | KR | 10-1761958 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | NL | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | TW | I469797 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | US | 9066868 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | US | 8470382 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | CARNIKING® L-carnitine | JP | 6982956 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | CARNIKING® L-carnitine | US | 10016382 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | CN | ZL 201010262857.2 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | CZ | 1901715 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | DE | 60 2006 029 269.4 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | IT | 1901715 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | JP | 5149172 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | KR | 1327700 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Carnipure®/CARNIKINGTM L-Carnitine | US | 9084431 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | JP | 6234030 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | KR | 10-1823971 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | CH | 2569275 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | CN | ZL201180019495.7 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | CZ | 2569275 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | DE | 2569275 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | CH | 2393578 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | IN | 292185 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | IT | 2569275 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | JP | 6018046 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | KR | 10-1848763 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | CN | ZL201080006621.0 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | DE | 2393578 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | JP | 6242565 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | KR | 10-1728562 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | CH | 2501673 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | CH | 2613778 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | US | 8604237 |
A Process for the Hydrogenation of Ketoesters | Carnipure® L-Carnitine | US | 8431741 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | CN | ZL201180042646.0 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | CZ | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | DE | 2613778 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | CN | 201080051331.8 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | IN | 293603 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | IT | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | JP | 5964831 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | KR | 10-1899015 |
Process for the Production of L-Carnitine Tartrate | Carnipure® L-Carnitine | US | 8779188 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | US | 8168823 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | CN | 200880117375.9 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | DE | 60 2008 009 662.9 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | IN | 271284 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | IT | 2231587 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | JP | 5155406 |
Process for the Preparation of Betaines | Carnipure® L-Carnitine | KR | 1132589 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | CZ | 2501673 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | DE | 2501673 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | IN | 308637 |
Methods for the Production of L-Carnitine | Carnipure® L-Carnitine | IT | 2501673 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnipure® L-Carnitine | US | 9415346 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | IN | 308970 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | IT | 2702032 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | JP | 6012709 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | US | 9227905 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnipure® L-Carnitine | US | 10130602 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | CH | 2702032 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnipure® L-Carnitine | JP | 6608858 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | CN | ZL1280020003.0 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | CZ | 2702032 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnipure® L-Carnitine | DE | 2702032 |
Scalable Process for Therapeutic Cell Concentration and Residual Clearance | Cell and Gene Therapies | US | 10385307 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | CH | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | DE | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | FR | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | GB | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | IT | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | NL | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | ES | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | SE | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | US | 9512474 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | CH | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | CN | 201480063730.4 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | DE | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | ES | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | FR | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | GB | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | IT | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | JP | 6479775 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | NL | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | SE | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | US | 10745668 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | ES | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | FR | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | GB | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | IL | 229462 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | IT | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | JP | 6140149 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | KR | 10-1970368 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | NL | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | SE | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | US | 9885019 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | US | 10487312 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | AU | 2012255724 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | AU | 2016238891 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | CA | 2836578 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | CH | 2718424 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | DE | 2718424 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | AU | 2017269371 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | CH | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | DE | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | FR | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | GB | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | JP | 6908331 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | CN | ZL200680050640.7 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | DE | 2184078 |
Biomimetic Cell Scaffolds | CellBio Services | DE | 2291512 |
Biomimetic Cell Scaffolds | CellBio Services | FR | 2291512 |
Biomimetic Cell Scaffolds | CellBio Services | GB | 2291512 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | FR | 2184078 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | GB | 2184078 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | JP | 5192387 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | CH | 2175897 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | CN | ZL200880103049.2 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | DE | 2175897 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | FR | 2175897 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | GB | 2175897 |
Biomimetic Cell Scaffolds | CellBio Services | US | 8580564 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | CH | 2184078 |
Methods for Producing Biomaterials with Variable Stiffness | CellBio Services | US | 8449902 |
Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | CH | 2197504 |
Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | DE | 2197504 |
Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | FR | 2197504 |
Biomaterial Scaffolds for Controlled Tissue Growth | CellBio Services | GB | 2197504 |
Bio-Artificial Materials with Tuneable Properties | CellBio Services | US | 8343758 |
Biomimetic Cell Scaffolds | CellBio Services | CH | 2291512 |
Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate® Ingredient | US | 7119110 |
Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate® Ingredient | MX | 250990 |
Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome | ChromeMate® Ingredient | US | 7153877 |
Advanced Tissue Engineering System | Cocoon® Platform | AU | 2005247967 |
Advanced Tissue Engineering System | Cocoon® Platform | CA | 2568438 |
Advanced Tissue Engineering System | Cocoon® Platform | CH | 1756262 |
Advanced Tissue Engineering System | Cocoon® Platform | DE | 1756262 |
Advanced Tissue Engineering System | Cocoon® Platform | FR | 1756262 |
Advanced Tissue Engineering System | Cocoon® Platform | GB | 1756262 |
Advanced Tissue Engineering System | Cocoon® Platform | IT | 1756262 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | US | 8546142 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | CA | 2599823 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | DE | 1730267 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | FR | 1730267 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | GB | 1730267 |
Reverse-flow Perfusion of Three-Dimensional Scaffolds | Cocoon® Platform | IT | 1730267 |
Advanced Tissue Engineering System | Cocoon® Platform | US | 9499780 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | AT | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | ES | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | FI | 2330181 |
Automated Tissue Engineering System | Cocoon® Platform | US | 10844338 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | US | 9701932 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | AU | 2003218572 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | AU | 2009202146 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | FR | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | GB | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | IE | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | IT | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | AU | 2012205259 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | AU | 2009202476 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | BE | 2330181 |
Automated Tissue Engineering System | Cocoon® Platform | JP | 6586407 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | NL | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | US | 8492140 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | CA | 2853267 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | CA | 2485350 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | CH | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | DE | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | DK | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | SE | 2330181 |
Automated System for Production of Tissue Engineered Products | Cocoon® Platform | US | 9534195 |
Automated Tissue Engineering System | Cocoon® Platform | US | 10723986 |
Automated Cell Culture System | Cocoon® Platform | CA | 2833001 |
Automated Cell Culture System | Cocoon® Platform | US | 9783768 |
End-To-End Cell Therapy Automation | Cocoon® Platform | KR | 10-2296580 |
Pectin Film Compositions | DFS Modified/Controlled/Targeted Release | US | 7041315 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | BE | 3082778 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | FR | 3082778 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | GB | 3082778 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid | DFS Modified/Controlled/Targeted Release | US | 10188611 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | DFS Modified/Controlled/Targeted Release | DE | 3082778 |
Capsule Formulation | DFS Multiparticulates | JP | 6588193 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | CH | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | DE | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | ES | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | SE | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | FR | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | GB | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | IT | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | CA | 2978080 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | IN | 385511 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | JP | 6733872 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | US | 10159244 |
Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | DE | 60348508.1 |
Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | FR | 1469829 |
Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | GB | 1469829 |
Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | US | 9211261 |
Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules | Dosage Form | JP | 6796083 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | CH | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | DE | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | SE | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | IT | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | FR | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | GB | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | NL | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | US | 11156614 |
Device and Method for Improved Closure Integrity | Fill-Finish Services - Helium Leak Testing | CH | 3681571 |
Device and Method for Improved Closure Integrity | Fill-Finish Services - Helium Leak Testing | DE | 3681571 |
Device and Method for Improved Closure Integrity | Fill-Finish Services - Helium Leak Testing | FR | 3681571 |
Device and Method for Improved Closure Integrity | Fill-Finish Services - Helium Leak Testing | GB | 3681571 |
Device and Method for Improved Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | US | 10801913 |
Device and Method for Improved Closure Integrity | Fill-Finish Services - Helium Leak Testing | JP | 7042901 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | JP | 6983310 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | US | 10895514 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | CH | 3682219 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | DE | 3682219 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | FR | 3682219 |
Device and Method for Improved Container Closure Integrity Testing | Fill-Finish Services - Helium Leak Testing | GB | 3682219 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | CN | ZL201080017207.X |
Process For Performing An In-Situ-Quench Reaction | FlowPlate® Microreactor Technology | DE | 1500649 |
Process For Performing An In-Situ-Quench Reaction | FlowPlate® Microreactor Technology | FR | 1500649 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | HK | HK1164779 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | JP | 5774580 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | CN | 200780027369 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | DE | 602007014375.6 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | FR | 2044087 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | GB | 2044087 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | JP | 5512266 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | US | 9023296 |
Process For Performing An In-Situ-Quench Reaction | FlowPlate® Microreactor Technology | GB | 1500649 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | CN | 101605800 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | DE | 60 2008 002 321.4-08 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | FR | 2109616 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | GB | 2109616 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | JP | 5394258 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | CN | 102421518 |
Method For Grignard Type Reactions In Microreactors | FlowPlate® Microreactor Technology | US | 7939698 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | HK | 1170447 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | US | 9302243 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | JP | 6062244 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | HK | 1128007 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | JP | 6234959 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | US | 8512653 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | US | 9375698 |
Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate® Microreactor Technology | US | 10058840 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | CN | 101415485 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | DE | 1839739 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | US | 9962678 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | US | 7919056 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | GB | 1839739 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | FR | 1839739 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | US | 8287824 |
Method For Lithium Exchange Reactions | FlowPlate® Microreactor Technology | US | 8198487 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | DE | 3031518 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | FR | 3031518 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | GB | 3031518 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | JP | 6759208 |
Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate® Microreactor Technology | JP | 5718335 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | JP | 5209693 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | KR | 976098 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | LU | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | NL | 1525320 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | KR | 1273829 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | ES | 2152728 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | FR | 2152728 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | GB | 2152728 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | PT | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | RO | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | SE | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | SG | 109715 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | SI | 1525320 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | JP | 5301534 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | SK | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | TR | 2009 00640 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | US | 7932087 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | SG | 182147 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | US | 8241870 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | AT | E412761 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | AU | 2009200665 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | AU | 2003251434 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | BE | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | BG | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | CA | 2489016 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | AU | 2006237193 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | CA | 2672809 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | CH | 1525320 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | HK | 1119737 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | IN | 257246 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | CN | ZL03816914.2 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | CZ | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | DE | 603 24 430.0-08 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | AU | 2006249087 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | CH | 1915394 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | DK | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | EE | E002975 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | ES | 2314248 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | FI | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | FR | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | GB | 1525320 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | CN | 200680017582.8 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | DE | 1915394 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | ES | 1915394 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | FR | 1915394 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | GB | 1915394 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | GR | 20090400053 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | HK | 1081595 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | HU | E004531 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | IE | 1525320 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | HK | HK1120050 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | IL | 187100 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | IN | 263242 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | IT | 1915394 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | IN | 229233 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | JP | 4991705 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | IT | 1525320 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | JP | 4430535 |
Method Of Expressing Recombinant Protein In CHO Cells | GS GENE EXPRESSION SYSTEM® | JP | 5502406 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | CN | CN 101687910 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | DE | 60 2008 022 892.4 |
Customizable Facility | Ibex® Solutions | US | 11236520 |
Customizable Facility | Ibex® Solutions | IL | 261709 |
Customizable Facility | Ibex® Solutions | US | 10689873 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | CA | 2589937 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | CH | 1824980 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | CN | 101090969 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | DE | 60 2005 020 972.7 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | HK | 1115156 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | IL | 183608 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | IT | 1824980 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | JP | 5069124 |
Reactor Surface Finish Effect On Cleanability | Mammalian Biopharmaceutical Services | US | 10808216 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | DK | 1824980 |
Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | ES | 1824980 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | FR | 1824980 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | EM | 001268353 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | JP | 1431555 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | AT | E466090 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | BE | 1824980 |
Rhamnose promoter expression system | Mammalian Biopharmaceutical Services | GB | 1824980 |
Antibody Purification By Protein A And Ion Exchange Chromatography | Mammalian Biopharmaceutical Services | CN | 200480009347.7 |
Antibody Purification By Protein A And Ion Exchange Chromatography | Mammalian Biopharmaceutical Services | JP | 5752558 |
Antibody Purification By Protein A And Ion Exchange Chromatography | Mammalian Biopharmaceutical Services | SG | 114308 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | AT | 1824961 |
Protein A Chromatography | Mammalian Biopharmaceutical Services | US | 7847071 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | BE | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | CA | 2589823 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | CH | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | CN | 101090963 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | DE | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | DK | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | ES | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | FR | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | GB | 1824961 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | BE | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | CH | 3540040 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | HK | 1115155 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | IE | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | IL | 183609 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | IT | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | JP | 5080269 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | CH | 2393912 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | DE | 602010064092.2. |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | DE | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | ES | 3540040 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | NL | 1824961 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | SG | 132972 |
Melibiose Operon Expression System | Mammalian Biopharmaceutical Services | US | 8735099 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | FR | 2393912 |
Bioreactor For The Cultivation of Mammalian Cells | Mammalian Biopharmaceutical Services | FR | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | GB | 2393912 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | GB | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | IT | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | JP | 6121374 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | US | 9670446 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | US | 9783771 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | US | 10179898 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | US | 10883076 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | EM | 001238208 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | SE | 1824980 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | SG | 149071 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | SG | 132976 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | US | 9279128 |
Rhamnose Promoter Expression System | Mammalian Biopharmaceutical Services | NL | 1824980 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | BE | 1516275 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | CH | 1516275 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | DE | 1516275 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | FR | 1516275 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | GB | 1516275 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | US | 7702465 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | ES | 3645720 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | FR | 3645720 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | GB | 3645720 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | IT | 3645720 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | US | D664262 |
Wireless Sensor Information Monitoring | Mammalian Biopharmaceutical Services | US | 10244406 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | US | 10436338 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | CH | 3645720 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | DE | 3645720 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | DE | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | DK | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | EA | 034039 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | ES | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | CZ | 2864489 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | SE | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | SE | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | SG | 11201502243Y |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | TR | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | FI | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | FR | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | GB | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | HK | 1202580 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | TW | I507526 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | US | 10294491 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | US | 9777290 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | TR | 2898077 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | GB | 90012683530002 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | GB | 90012683530001 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | HU | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | IE | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | IL | 236347 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | JP | 6053923 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | IN | 346058 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | KR | 10-1761709 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | IT | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | MX | 351727 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | NO | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | PL | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | SG | 11201408576Q |
Site-Specific Integration | Mammalian Biopharmaceutical Services | TW | I523946 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | US | 10280436 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | AT | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | TR | 2864489 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | AT | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | AU | 2013320157 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | BE | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | BE | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | BR | 1120150056040 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CA | 2880750 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CH | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CH | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CN | ZL201380049575.6 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CZ | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | CZ | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | DE | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | DE | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | DK | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | DK | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | EA | EA 033008 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | ES | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | ES | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | FI | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | FI | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | FR | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | FR | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | GB | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | GB | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | HK | HK1206061 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | HU | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | HU | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IE | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IE | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IL | 237171 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IT | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IT | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | JP | 6162246 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | IN | 333092 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | AT | 2864489 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | KR | 10-1757083 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | MX | 371007 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | NL | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | NL | 2898077 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | AU | 2013279333 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | BE | 2864489 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | BR | 1120140322996 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | CA | 2876280 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | CN | 104379753 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | NO | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | NO | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | PL | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | PL | 2898077 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | AU | 2017277761 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | US | 10975409 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | AU | 2016338676 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | AU | 2017259010 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | Mammalian Biopharmaceutical Services | JP | 6932649 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | IL | 258633 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | US | 10370629 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | Mammalian Biopharmaceutical Services | US | 10953106 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | SG | 11201803017Q |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | US | 10655111 |
Method And System For Providing Buffer Solutions | Mammalian Biopharmaceutical Services | US | 10669518 |
A Method For The Reduction Of Viral Titer In Pharmaceuticals | Mammalian Biopharmaceutical Services | US | 11034721 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | CN | ZL201780083077.1 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | US | 10570363 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | CH | 3341484 |
Wireless Sensor Information Monitoring | Mammalian Biopharmaceutical Services | US | 11006260 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | JP | 6942736 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | DE | 3341484 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | FR | 3341484 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | GB | 3341484 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | US | 10801003 |
Method for Preparation of 1,4-Sorbitan | Manufacturing Processes of Pharmaceutical Excipients | KR | 10-2312129 |
Method for Preparation of 1,4-Sorbitan | Manufacturing Processes of Pharmaceutical Excipients | US | 11174236 |
Aseptic Sampling Module and Manifold | MAST® System | DE | 3004318 |
Aseptic Sampling Module and Manifold | MAST® System | ES | 3004318 |
Aseptic Sampling Module and Manifold | MAST® System | FR | 3004318 |
Aseptic Sampling Module and Manifold | MAST® System | GB | 3004318 |
Aseptic Sampling Module and Manifold | MAST® System | IE | 3004318 |
Systems and Methods for Producing Bioproducts | MAST® System | US | 10421939 |
Systems and Methods for Producing Bioproducts | MAST® System | US | 10836991 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | CH | 2800966 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | DE | 2800966 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | ES | 2800966 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | FR | 2800966 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | GB | 2800966 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | IE | 2800966 |
Automatic Sampling System for Sampling from Enclosed Containers | MAST® System | US | 9322749 |
Fixed Volume Aseptic Sampling Valve for Sampling from Enclosed Containers | MAST® System | US | 9389151 |
Dielectric Spectroscopy Methods and Apparatus | MAST® System | US | 9568449 |
Automatic Aseptic Sampling Valve For Sampling From Enclosed Containers | MAST® System | US | 9499782 |
Aseptic Sampling Module and Manifold | MAST® System | CH | 3004318 |
Disposable Cell Removal System | MAST® System | JP | 6932171 |
Disposable Cell Removal System | MAST® System | JP | 6619429 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | DE | 602004050023.2 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | ES | 1689368 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | FR | 1689368 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | GB | 1689368 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | IT | 1689368 |
Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | JP | 5072355 |
Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | US | 9192679 |
Novel Galenical System For Active Transport, Method For Preparation And Use | Multiparticulates | US | 8911788 |
Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | US | 8236349 |
Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | DE | 602005003343.2 |
Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | FR | 1737433 |
Taste-Masked Drugs In Rupturing Multiparticulates | Multiparticulates | GB | 1737433 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | DE | 602007041896.8 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | FR | 2091519 |
Method For Making Pharmaceutical Multiparticulates | Multiparticulates | DE | 602004014805.9 |
Method For Making Pharmaceutical Multiparticulates | Multiparticulates | FR | 1691787 |
Method For Making Pharmaceutical Multiparticulates | Multiparticulates | GB | 1691787 |
Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride | Multiparticulates | BE | 1689368 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | GB | 2091519 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | US | 10357462 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | US | 11116728 |
Extrusion Process For Forming Chemically Stable Drug Multiparticulates | Multiparticulates | US | 7625507 |
Multiparticulate Compositions With Improved Stability | Multiparticulates | US | 7736672 |
Multiparticulate Crystalline Drug Compositions Having Controlled Release Profiles | Multiparticulates | US | 7887844 |
Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | BE | 3154529 |
Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | CH | 3154529 |
Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | DE | 3154529 |
Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | FR | 3154529 |
Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use | Multiparticulates | GB | 3154529 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | DE | 602014004180.9 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | ES | 2949309 |
Apparatus and Process for Filling Particular Materials | Multiparticulates | FR | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | GB | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | BE | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | IT | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | US | 10835451 |
Method and Composition for Increasing Muscle Protein Synthesis and/or Functional Strength in Mammals | MuscleGuard® Formulation | US | 10888571 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | AU | 2004233290 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | BR | PI0407750-4 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | CA | 2512636 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | CN | ZL200480005692.3 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | DE | 2264181 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | GB | 2400659 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | HK | 1148790 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | JP | 4987469 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | KR | 1162738 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | NO | 333474 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | SG | 114840 |
Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity | MYCOALERT® Mycoplasma Detection Kit | US | 7585644 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | GB | 1702677 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | IT | 1702677 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | IT | 1577378 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | GB | 1383901 |
Nucleofector Device" | Nucleofector® System | DE | 50201240.4 |
Nucleofector Device" | Nucleofector® System | ES | 1390518 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | US | 8450102 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | FR | 1525900 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | GB | 1525900 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | GB | 1698372 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | DE | 502004005342.4 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | DE | 502004009820.7 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | DK | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | JP | 4680254 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | KR | 1077008 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | NL | 1702677 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | IT | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | IT | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | JP | 4694587 |
Nucleofector Device" | Nucleofector® System | FR | 1390518 |
Nucleofector Device" | Nucleofector® System | GB | 1390518 |
Nucleofector Device" | Nucleofector® System | IT | 1390518 |
Nucleofector Device" | Nucleofector® System | JP | 4070611 |
Device and Method for Processing Biological Material | Nucleofector® System | CH | 1543102 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | ES | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | ES | 1702677 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | NL | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | PL | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | SE | 1702677 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | SE | 1577378 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | JP | 4124659 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | KR | 0810173 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | NL | 1383901 |
Device and Method for Processing Biological Material | Nucleofector® System | CN | ZL03824843.3 |
Device and Method for Processing Biological Material | Nucleofector® System | DE | 50312452.4 |
Device and Method for Processing Biological Material | Nucleofector® System | DK | 1543102 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | US | 9284525 |
Device and Method for Processing Biological Material | Nucleofector® System | FI | 1543102 |
Device and Method for Processing Biological Material | Nucleofector® System | FR | 1543102 |
Device and Method for Processing Biological Material | Nucleofector® System | GB | 1543102 |
Device and Method for Processing Biological Material | Nucleofector® System | SE | 1543102 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | AU | 2006268953 |
Device and Method for Processing Biological Material | Nucleofector® System | US | 7704727 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | CA | 2613984 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | CH | 1741778 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | CN | 200680024248.5 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | CH | 2399984 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | AT | 1607484 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | DE | 502005002350.1 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | FR | 1741778 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | GB | 1741778 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | CH | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | CN | ZL201180030236.4 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | CN | ZL201180030237.9 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | DE | 502010016602.5 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | US | 8173416 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | CH | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | DE | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | ES | 1607484 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | HK | 1122840 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | JP | 4982489 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | AT | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | BE | 2208779 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | DE | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | ES | 2413557 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | ES | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | FR | 2399984 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | AU | 2003227006 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | CA | 2476439 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | CH | 1476537 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | AU | 2004283543 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | JP | 5032847 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | JP | 5124661 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | KR | 1130878 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | AT | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | AT | 1702677 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | FR | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | GB | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | IT | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | NL | 1607484 |
Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | US | 9249384 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | CH | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | DE | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | ES | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | FR | 2208779 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | FR | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | GB | 2399984 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | GB | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | IE | 2399984 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | IE | 2399985 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | US | 7732175 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | JP | 4369241 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | KR | 0852288 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | US | 7678564 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | AT | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | CN | ZL02802650.3 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | DE | 50201472.5 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | DE | 50212037.1 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher | Nucleofector® System | NL | 1522587 |
Nucleofector Device" | Nucleofector® System | KR | 0845057 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | CA | 2542902 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | CH | 1525900 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | CH | 1698372 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produced by this Method | Nucleofector® System | US | 8895152 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | AU | 2005224452 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | AU | 2011200804 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | AU | 2011244905 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | BE | 1702677 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | SE | 1607484 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | US | 8058042 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | GB | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | IT | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | JP | 5560288 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | JP | 5840204 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | JP | 5885144 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | KR | 10-1853515 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | US | 8101401 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | AT | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | AU | 2007202279 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | AU | 2002315659 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | ES | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | ES | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | FR | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | FR | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | SE | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | SE | 1522587 |
Nucleofector Device" | Nucleofector® System | KR | 0879824 |
Nucleofector Device" | Nucleofector® System | NL | 1390518 |
Nucleofector Device" | Nucleofector® System | SE | 1390518 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | DE | 50312163.0 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | BE | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CA | 2559580 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CH | 1702677 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | KR | 1686258 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | NL | 2208779 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | SE | 2208779 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | KR | 10-1853514 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | NL | 2399984 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | NL | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | SE | 2399984 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | SE | 2399985 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | CN | ZL03805811.1 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | BE | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | BE | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | CA | 2445257 |
Nucleofector Device" | Nucleofector® System | AT | 1390518 |
Nucleofector Device" | Nucleofector® System | AU | 2007202057 |
Nucleofector Device" | Nucleofector® System | AU | 2002315658 |
Nucleofector Device" | Nucleofector® System | US | 8192990 |
Nucleofector Device" | Nucleofector® System | US | 7332332 |
Nucleofector Device" | Nucleofector® System | US | 8039259 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | DE | 50303219.0 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method | Nucleofector® System | FR | 1698372 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CH | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CN | ZL 200580007908.4 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CN | ZL 201210074701.0 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | CZ | 1577378 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | AT | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | BE | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | CH | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | DE | 2208780 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | US | 9701954 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | US | 11021698 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | CH | 1522587 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | CH | 1383901 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | GB | 1522587 |
Nucleofector Device" | Nucleofector® System | BE | 1390518 |
Nucleofector Device" | Nucleofector® System | CA | 2445260 |
Nucleofector Device" | Nucleofector® System | CH | 1390518 |
Nucleofector Device" | Nucleofector® System | CN | ZL02808704.6 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | CH | 1961807 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | DE | 1961807 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | DK | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | ES | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | FI | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | FR | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | US | 9080139 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | DE | 50300761.7 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | FR | 1476537 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | GB | 1476537 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | ES | 1961807 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | FR | 1961807 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | GB | 1961807 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | GB | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | IE | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | IT | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | JP | 6013419 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | FR | 1577378 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | FR | 1702677 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | IT | 1961807 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | NL | 1961807 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | SE | 1961807 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | KR | 1686260 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | NL | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | NO | 2208780 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | SE | 2208780 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | US | 7700357 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | GB | 1577378 |
Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | JP | 5926560 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | US | 9624486 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | AT | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | BE | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | CH | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | DE | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | DK | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | ES | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | FI | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | FR | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | GB | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | IE | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | IT | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | NL | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | NO | 3750983 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | SE | 3750983 |
Device and Method for Large Volume Transfection | Nucleofector® System | AT | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | AT | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | AU | 2018205130 |
Device and Method for Large Volume Transfection | Nucleofector® System | AU | 2015254741 |
Device and Method for Large Volume Transfection | Nucleofector® System | AU | 2015254739 |
Device and Method for Large Volume Transfection | Nucleofector® System | BE | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | BE | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | CH | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | CH | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | CH | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | CN | 106459872 |
Device and Method for Large Volume Transfection | Nucleofector® System | CN | 106255746 |
Device and Method for Large Volume Transfection | Nucleofector® System | DE | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | DE | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | DE | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | DK | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | ES | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | DK | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | DK | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | ES | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | ES | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | FI | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | FI | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | FR | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | FR | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | FR | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | GB | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | GB | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | GB | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | IE | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | IE | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | IN | 364412 |
Device and Method for Large Volume Transfection | Nucleofector® System | IN | 359428 |
Device and Method for Large Volume Transfection | Nucleofector® System | IT | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | IT | 502019000085478 |
Device and Method for Large Volume Transfection | Nucleofector® System | IT | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | JP | 6642875 |
Device and Method for Large Volume Transfection | Nucleofector® System | NL | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | NL | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | JP | 6750810 |
Device and Method for Large Volume Transfection | Nucleofector® System | NL | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | NO | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | NO | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | SE | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | SE | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | US | 10336996 |
Device and Method for Large Volume Transfection | Nucleofector® System | US | 10633646 |
Device and Method for Large Volume Transfection | Nucleofector® System | SE | 2940121 |
Nucleofector Device" | Nucleofector® System | US | 8003389 |
Pharmaceutical Compositions of Dispersions Of Amorphous Drugs Mixed with Polymers | Other Solubilization | US | 8703196 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | CA | 2448825 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | US | 8703199 |
Nanoparticles Comprising Drug, A Non-Ionizable Cellulosic Polymer And Tocopheryl Polyethylene Glocol Succinate | Other Solubilization | US | 9545384 |
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | DE | 602008044103.2 |
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | FR | 2231169 |
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | GB | 2231169 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug | Other Solubilization | US | 8389006 |
Pharmaceutical Dosage Forms Comprising A Low-Solubility Drug And A Polymer | Other Solubilization | US | 9445998 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | DE | 602004036099.6 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | FR | 1653927 |
Pharmaceutical Compositions Containing A Solid Dispersion Of A Poorly-Soluble Drug And A Solubility-Enhancing Polymers | Other Solubilization | US | 8236328 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | GB | 1653927 |
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | IE | 1653927 |
REISSUE-Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | US | RE47033 |
Pharmaceutical Compositions Of Semi-Ordered Drugs And Polymers | Other Solubilization | US | 8257739 |
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material | Other Solubilization | US | 9724362 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | BE | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | CH | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | DE | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | FR | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | GB | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | IE | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | JP | 6650933 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | PT | 3212169 |
Methods And Compositions For Maintaining Active Agents In Intra-Articular Spaces | Other Solubilization | US | 9084727 |
Methods and Kits for Detecting Protein Kinase | PKLIGHT® HTS Protein Kinase Assay Kit | US | 6911319 |
Composition for Protein Detection | PROSIEVE® Products | NL | 3599244 |
Protein Detection | PROSIEVE® Products | NL | 2744817 |
Protein Detection | PROSIEVE® Products | US | 9377467 |
Protein Detection | PROSIEVE® Products | US | 9091694 |
Protein Detection | PROSIEVE® Products | GB | 2744817 |
Protein Detection | PROSIEVE® Products | IN | 357896 |
Protein Detection | PROSIEVE® Products | JP | 6074428 |
Protein Detection | PROSIEVE® Products | JP | 6475671 |
Composition for Protein Detection | PROSIEVE® Products | GB | 3599244 |
Protein Detection | PROSIEVE® Products | CN | ZL201710139782.0 |
Protein Detection | PROSIEVE® Products | CN | ZL201280050243.5 |
Composition for Protein Detection | PROSIEVE® Products | DE | 3599244 |
Protein Detection | PROSIEVE® Products | DE | 2744817 |
Protein Detection | PROSIEVE® Products | ES | 2744817 |
Composition for Protein Detection | PROSIEVE® Products | ES | 3599244 |
Composition for Protein Detection | PROSIEVE® Products | FR | 3599244 |
Protein Detection | PROSIEVE® Products | FR | 2744817 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | JP | 5039729 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | LU | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | MX | 254052 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | NL | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | PT | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | SE | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | TR | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | AT | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | BE | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | BR | PI0210681-7 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | CH | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | CN | ZL02814296.9 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | CY | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | DE | 60233142.0 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | DK | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | ES | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | FI | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | GB | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | IE | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | IT | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | FR | 1409984 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | AU | 2002330860 |
Methods and Reagents for Detecting Endotoxin | PYROGENE® rFc Assay | US | 6849426 |
Dynamically Controlling an Automated System | PyroTec® Pro System | MX | 387422 |
Dynamically Controlling an Automated System | PyroTec® Pro System | US | 10768190 |
Dynamically Controlling an Automated System | PyroTec® Pro System | US | 10928407 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | CH | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | CN | ZL201180039793.2 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | DE | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | ES | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | FR | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | GB | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | IT | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | NL | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | SE | 2580313 |
Apparatus, Kits and Methods for the Production of Biomimetic Constructs | RAFT® 3D Cell Culture System | US | 9707703 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | CH | 1773416 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | CN | ZL200580022828.6 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | DE | 1773416 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | FR | 1773416 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | GB | 1773416 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | JP | 4971981 |
Cell-Independant Fabrication of Tissue Equivalents | RAFT® 3D Cell Culture System | US | 9101693 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | AU | 2010301525 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | CH | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | DE | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | EA | 024010 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | ES | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | FR | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | GB | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | IT | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | JP | 6181121 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | JP | 5844261 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | KR | 10-1787124 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | NL | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | NZ | 599077 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | SE | 2482826 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | US | 9549979 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | US | 9302000 |
Arabinogalactan for Enhancing the Adaptive Immune Response | ResistAid® Arabinogalactan | US | 8784844 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | AU | 2013231673 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | JP | 6490662 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | SG | 10201707481S |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | ResistAid® Arabinogalactan | US | 9393259 |
Method For Preparation Of N-Carboxyanhydrides | Small Molecules - API | DE | 3810579 |
Method For Preparation Of N-Carboxyanhydrides | Small Molecules - API | FR | 3810579 |
Method For Preparation Of N-Carboxyanhydrides | Small Molecules - API | GB | 3810579 |
Method For Preparation Of N-Carboxyanhydrides | Small Molecules - API | CH | 3810579 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | GB | 3619188 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | HK | 40019698 B |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | JP | 6737967 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | US | 11001552 |
Method For Preparation Of Difluoromethylornithine | Small Molecules - API | CH | 3634943 |
Method For Preparation Of Alpha-Methyl-L-Proline | Small Molecules - API | CN | 110799493 |
Method For Preparation Of Alpha-Methyl-L-Proline | Small Molecules - API | HK | 40017759B |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | DE | 3619188 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | FR | 3619188 |
Method For Preparation Of Difluoromethylornithine | Small Molecules - API | DE | 3634943 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | CH | 3619188 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | Small Molecules - API | CN | 110944974 |
Method For Preparation Of Difluoromethylornithine | Small Molecules - API | FR | 3634943 |
Method For Preparation Of Difluoromethylornithine | Small Molecules - API | GB | 3634943 |
Method For Preparation Of Difluoromethylornithine | Small Molecules - API | JP | 6781858 |
Method For Preparation Of N-Carboxyanhydrides | Small Molecules - API | JP | 7042969 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | CA | 2862553 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | CH | 2806856 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | DE | 2806856 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | IT | 1409966 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | JP | 6158225 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | CH | 2838661 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | DE | 2838661 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | IT | 1411465 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | US | 9427743 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | FR | 3519100 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | GB | 3519100 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | HK | HK40008244 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | US | 11260396 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | CN | CN 109789424 B |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | DE | 3519100 |
Drying Of Drug-Containing Particles | Spray Drying | US | 9265731 |
Drying Of Drug-Containing Particles | Spray Drying | DE | 602007041938.7 |
Drying Of Drug-Containing Particles | Spray Drying | FR | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | GB | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | IE | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | PT | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | US | 8834929 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | CA | 2472028 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | JP | 4865989 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | US | 6973741 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | US | 8343550 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | US | 8828443 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | US | 9339467 |
Spray-Drying Process | Spray Drying | BE | 3130396 |
Spray-Drying Process | Spray Drying | CH | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | BE | 1855652 |
Drying Of Drug-Containing Particles | Spray Drying | DE | 602006047398.2 |
Spray-Drying Process | Spray Drying | DE | 3130396 |
Spray-Drying Process | Spray Drying | DE | 602010036172.1 |
Spray-Drying Process | Spray Drying | ES | 3130396 |
Spray-Drying Process | Spray Drying | FR | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | FR | 1855652 |
Drying Of Drug-Containing Particles | Spray Drying | GB | 1855652 |
Drying Of Drug-Containing Particles | Spray Drying | IE | 1855652 |
Drying Of Drug-Containing Particles | Spray Drying | PT | 1855652 |
Spray-Drying Process | Spray Drying | FR | 2411137 |
Spray-Drying Process | Spray Drying | GB | 2411137 |
Spray-Drying Process | Spray Drying | GB | 3130396 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | DE | 602004036819.9 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | FR | 1653928 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | GB | 1653928 |
Spray-Drying Process | Spray Drying | IE | 3130396 |
Spray-Drying Process | Spray Drying | IT | 3130396 |
Spray-Drying Process | Spray Drying | PT | 3130396 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | IE | 1653928 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | PT | 1653928 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | TW | I290852 |
Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers | Spray Drying | US | 10383941 |
Spray-Drying Process | Spray Drying | US | 10675602 |
Spray-Drying Process | Spray Drying | US | 10300443 |
Spray-Drying Process | Spray Drying | US | 9724664 |
Method For Making Homogeneous Spray-Dried Soild Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | US | 6763607 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Using Pressure Nozzles | Spray Drying | US | 7780988 |
Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | US | 9358478 |
Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | US | 9084976 |
Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | US | 9205345 |
Spray-Drying Apparatus And Methods Of Using The Same | Spray Drying | US | 9084944 |
High-Temperature Spray Drying Process And Apparatus | Spray Drying | US | 9248584 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | DE | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | GB | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | FR | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | ES | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | BE | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | IT | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | CH | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | IE | 1469833 |
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Utilizing Modified Spray-Drying Apparatus | Spray Drying | PT | 1469833 |
Method and Composition for Supporting Weight Loss | Super CitriMax® Ingredient | AU | 2002305132 |
Method and Composition for Supporting Weight Loss | Super CitriMax® Ingredient | NZ | 528681 |
Method and Composition for Supporting Weight Loss | Super CitriMax® Ingredient | US | 7335651 |
Method and Composition for Supporting Weight Loss | Super CitriMax® Ingredient | ZA | 2003/07594 |
Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | KR | 10-1611374 |
Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | TW | I510500 |
Method for Producing Biologically Active Products | UC-II® Collagen | BE | 1435906 |
Method for Producing Biologically Active Products | UC-II® Collagen | CA | 2459981 |
Method for Producing Biologically Active Products | UC-II® Collagen | DE | 1435906 |
Method for Producing Biologically Active Products | UC-II® Collagen | FR | 1435906 |
Method for Producing Biologically Active Products | UC-II® Collagen | GB | 1435906 |
Method for Producing Biologically Active Products | UC-II® Collagen | JP | 4800574 |
Method for Producing Biologically Active Products | UC-II® Collagen | NL | 1435906 |
Method for Producing Biologically Active Products | UC-II® Collagen | US | 7846487 |
Method for Producing Biologically Active Products | UC-II® Collagen | US | 7083820 |
Improved Collagen Dispersion and Method of Producing Same | UC-II® Collagen | US | 8748499 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | AU | 2014202041 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | CA | 2846644 |
Method of Reducing Exercise-Induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | CL | 61835 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | KR | 10-1664290 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | MX | 347669 |
Method of Reducing Exercise-Induced Joint Pain in Non-Arthritic Mammals | UC-II® Collagen | MY | MY-180106-A |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | PH | 2014/50143 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | SG | 11201403524R |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | UC-II® Collagen | US | 9066926 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | DE | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | ES | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | FR | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | GB | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | IN | 321319 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | IT | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | JP | 5997140 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | NL | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | PL | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | SE | 2591121 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | AT | 965820 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | CA | 2803719 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | CH | 2591121 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6974341 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | CN | 103097542 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | US | 8962277 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | CH | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DE | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | ES | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | FR | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | GB | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IT | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | BE | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DK | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | NL | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IE | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | SE | 3508494 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | AT | 3508494 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | US | 9150870 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IN | 386019 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6698352 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | KR | 10-2128959 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | AT | ATE1107543 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | NL | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | SE | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | SG | 11201507557U |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | CH | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | DE | 3332005 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | BE | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | CH | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DE | 2764016 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | US | 11168117 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | US | 10428123 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | ES | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | FR | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | GB | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | IT | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | BE | 3332005 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DK | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | ES | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | FR | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | GB | 2764016 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | BE | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | AT | 843821 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | AT | 1231985 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | DK | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | NL | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | IE | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | SE | 3332005 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | AT | 3332005 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IE | 2764016 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IL | 231859 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IT | 2764016 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | CH | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | CH | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | CN | ZL201380056279.9 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6113736 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | KR | 10-2128957 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | KR | 10-1954389 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | NL | 2764016 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | DE | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | DE | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | DK | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | ES | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | ES | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | US | 10301634 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | SE | 2764016 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | FR | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | FR | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | GB | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | GB | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | HK | HK1208037 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IE | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IL | 238420 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IL | 266700 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IT | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | IT | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6556625 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | US | 9512432 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | KR | 102079293 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | NL | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | SE | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | NL | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | SG | 11201502745X |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | US | 10160988 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | AT | ATE1155873 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | BE | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | CH | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DE | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DK | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | ES | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | FR | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IE | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IT | 2970994 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | GB | 2970994 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | CH | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | DE | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | ES | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | FR | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | GB | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | IT | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | NL | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | IE | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | SE | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | AT | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | BE | 3874047 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | DK | 3874047 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | ES | 2394668 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | FI | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | FR | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | GB | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | IE | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | NO | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | SE | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | AT | 578997 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | BE | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | BR | 112012002973-8 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | CH | 2284273 |
Vector Comprising Mannoses Promoter and Mannose Promoter | XS Technologies® - Microbial Biopharmaceutical Services | DK | 2284273 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | CN | ZL 201580032989.7 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | IL | 248376 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6833812 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | KR | 10-2253479 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | AU | 2016303026 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | CN | 108350447 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | US | 10865416 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | AT | 3132039 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | BE | 3132039 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | IN | 385062 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | SE | 2912053 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | CN | ZL201580032885.6 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | CH | 3132039 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | US | 10752907 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | DE | 602015034267.4 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | FR | 3132039 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | GB | 3132039 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | IL | 248361 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | JP | 6982607 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | KR | 10-2291978 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | NL | 3132039 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | US | 10590427 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | AU | 2015248807 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | AU | 2015248815 |
Trivalent Chromium Compounds, Compositions and Methods of Use | ZYCHROME® | CA | 2649103 |
Trivalent Chromium Compounds, Compositions and Methods of Use | ZYCHROME® | US | 9700546 |